Genome sequencing (GS) has emerged as a promising alternative to existing prenatal diagnostic methods. GS offers a single, high-resolution approach capable of simultaneously detecting a broad spectrum of genetic alterations below the detection threshold of CMA, impacting medical management in pregnancy, delivery, and neonatal care. In this webinar, we will assess the upcoming implementation of genomes sequencing as the first-tier prenatal diagnostic test for all patients and consider the implications for non-invasive exome/genome sequencing. We will additionally consider the value of community and data sharing to drive this field forward. 

Presented by:

NSGC Prenatal SIG
Jessica L. Giordano, MS, CGC 

Date:

February 4, 2026 

Learning Objectives: 

1. Examine the value of genome sequencing in prenatal diagnosis as a single-tier, comprehensive test for all patients
2. Assess benefits and limitations of different sequencing consenting and reporting strategies
3. Explore the future state of non-invasive exome/genome sequencing
4. Discuss the value of community and data sharing to move the field of prenatal diagnosis forward 

Genetic Counselor CEUs:

The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, The future is here: Genome Sequencing as the first line prenatal diagnostic testing. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

Successful Completion:

1. View recording
2. Pass quiz
3. Complete evaluation

Advancements in genomic knowledge and next generation sequencing technologies have resulted in expanded carrier screening creating more equitable opportunities for individuals to learn about their reproductive risks for various genetic conditions including inherited eye and hearing conditions.  For many of the ocular and auditory conditions included in carrier screening panels there are wide spectrums of phenotypic features including age of onset and severity.  In this webinar, we discuss some common carrier screening findings for ocular and auditory conditions and offer strategies for providing a nuanced approach to genetic counseling about ocular and auditory conditions.

Presented by: 

NSGC Ophthalmology and Hearing Loss SIG
1. Shay Guetz-Lindahl, MS, CGC
2. Emily Place, MS, LCGC

Learning Objectives:

1. Define the spectrum of presentation of ocular genetic conditions found on carrier screening.
2. Define the spectrum of presentation of hearing loss genetic conditions on carrier screening.

Genetic Counselor CEUs: 

The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, Spectrum of Senses: Insights and Caveats for navigating ocular and auditory genetics in prenatal and preconception counseling. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

Successful Completion: 

1. View recording
2. Pass quiz
3. Complete evaluation

Content expires December 31, 2027.

This webinar examines how genetic counselors are implementing pharmacogenomics (PGx) testing and counseling across healthcare settings. Over 95% of the population carries clinically significant pharmacogene variants, yet implementation lags behind other genetic testing due to limited workforce training, provider literacy gaps, and high clinical decision support costs. The presenters showcased three primary PGx service delivery models: academic medicine programs (Brigham & Women's Hospital telemedicine clinic and M Health Fairview's Go4PGx Initiative), private practice collaborations between genetic counselors and pharmacists, and laboratory-based models such as Color Health's integration with cancer clinics and research partnerships. Future challenges include managing increasingly complex sequencing-based and polygenic score PGx results while capitalizing on opportunities from long-read genomics and rapid sequencing technologies. Training programs and continuing education must expand to meet growing clinical integration of PGx and establish counselor competency as a hiring differentiator.

Presented by: 

NSGC Precision Medicine SIG
1. Hannah Llorin, MS, CGC
2. Elizabeth Fieg, MS, CGC
3. Hetanshi Naik, PhD, MS, CGC
4. Jen Eichmeyer, MS, CGC
5. Jeri Nichols, MS, PharmD, CGC, CSP
6. Carla McGruder, MS, CGC
7. Rissa Hall, MS, CGC

Learning Objectives:

1. Explain the clinical relevance and utility of pharmacogenomics (PGx)
2. Identify barriers to PGx implementation in genetic counseling practice and recognize emerging opportunities to advance the field
3. Compare genetic counselor roles and responsibilities across academic, private practice, and laboratory-based PGx models

Genetic Counselor CEUs: 

The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, From Niche to Necessary: Genetic Counselor-Led Pharmacogenomics Across the Care Continuum. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

Successful Completion: 

1. View recording
2. Pass quiz
3. Complete evaluation

This webinar will present recently published evidence-based, consensus driven practice recommendations for genetic testing of ataxias, focusing on an approach to clinical decision making, genetic counseling, and genetic testing. The presenters will highlight key updates from the publication, address common challenges, and discuss laboratory methodologies.

Presented by: 

NSGC Neurology SIG
Amy Mook, MS, MPH, CGC
Michelle Rochman, MS, CGC 

Date:

February 18, 2026 

Learning Objectives:

1. Describe the rationale for creating standardized genetic testing recommendations
2. Review the process for developing evidence-based, consensus driven guidelines
3. Recommend an approach for evaluation and counseling for patients with a personal and/or family history ataxia
4. Discuss considerations for test selection and associated methodologies 

Genetic Counselor CEUs:

The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .01 CEUs or 1 Category 1 contact hour for the activity, Practice Recommendations for Genetic Testing of Ataxias. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

Successful Completion: 

1. View recording
2. Pass quiz
3. Complete evaluation

Join the genetic counseling champions behind the NSGC Cancer Business Case Toolkit for an in-depth discussion of its development, strategic framework, and practical applications. This session will explore how the toolkit was created, how it can be effectively leveraged within your institution, and how its principles can inform the development of a compelling business case to integrate a genetic counselor into your practice.

Presented by:

Allison Harvey, MPH, CHES
Sara Pirzadeh-Miller, MS, CGC
Jaime Grund, MS, LGC
Stephanie Cohen, MS, LCGC
Charlie King, MGC, CGC
Kristen Shannon, MS, LCGC
Scott M. Weissman, MS, CGC

Date:

March, 16 2026

Learning Objectives:

1. Describe the core elements of the NSGC Business Case Toolkit for oncology genetic counseling services.
2. Describe how toolkit elements can be applied to your practice
3. Recognize the importance of clinical, financial, and operational metrics in developing a sustainable oncology genetics program

Genetic Counselor CEUs:

The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to 0.1 CEUs or 1 Category 1 contact hour for the activity, Making the Case: A Business Toolkit for Expanding Genetic Counseling in Oncology. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

Successful Completion:

1. View recording
2. Pass quiz
3. Complete evaluation

Join us for an engaging, case-based webinar that brings the realities of genetic counseling into focus through complex, real-world clinical scenarios. In this interactive session, expert genetic counselors will walk through challenging cases that highlight evolving genetic knowledge, nuanced risk assessment, and the counseling strategies needed to support patients facing difficult decisions.

Presented by: 

Rozalia Valentine, MS, CGC
Brettne Frewin Elizabeth Spitzer, PhD
Kendra Schaa, ScM, CGC
Laura Godfrey Hendon, MA, MS, LCGC

Date:

March 18, 2026

Learning Objectives:

1. Illustrate the role of a genetic counselor in client-centered decision-making
2. Demonstrate how genetic counselors fit within the larger healthcare system
3. Review the wide differential and one center’s testing strategy for fetal cystic hygroma.
4. Examine the impact of severe intrafamilial variable expressivity in a “lethal” Mendelian disorder on patient expectations and coping.
5. Assess the limitations of current NMD vs NDD classification frameworks in DYNC1H1-related disorders and their impact on accurate diagnostic prognostication
6. Integrate patient and caregiver narratives into genetic counseling practice to inform communication, expectation-setting, and support.

Genetic Counselor CEUs: 

The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, NSGC Case Based Webinar - Part One. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

Successful Completion:

1. View recording
2. Pass quiz
3. Complete evaluation

This 60-minute webinar, hosted by the NSGC Student/New Graduate Special Interest Group, explores the expanding landscape of genetic counseling careers beyond traditional clinical roles. While genetic counselors have historically worked in clinical roles, this session highlights the growing presence of professionals in non-clinical settings, including industry, research, education, and entrepreneurship. Through a combination of background context and panel discussions, attendees will gain insight into how skills learned in graduate training may be applied to different career paths.

Featuring speakers currently working in unique, non-clinical roles, the webinar will provide firsthand perspectives on career transitions, day-to-day responsibilities, and the application of core genetic counseling skills, such as communication, risk assessment, and critical thinking, in new professional contexts. Participants will also learn practical strategies for exploring these career paths, including networking, skill development, and positioning themselves for opportunities outside of direct patient care. The session concludes with a live Q&A and curated resources, with an emphasis on making career development more accessible and equitable for all trainees and early-career genetic counselors.

Presented by:

NSGC Student/New Graduate SIG
1. Rachel Hendricks MS, CGC
2. Somin Hwang MS, CGC
3. Grace Drew, BS
4. Gillian Hooker, PhD, ScM, CGC
5. Kira Dineen, MS, CGC, CG(ASCP)CM
6. Mackenzie Wooters, MS, CGC

Learning Objectives:

1. Describe the unique roles and responsibilities associated with genetic counseling positions in non-clinical settings
2. Identify key transferable skills gained through genetic counseling training (e.g., communication, risk assessment, critical thinking) and how they apply to a variety of professional roles.
3. Explain how genetic counseling competencies can be leveraged to pursue opportunities outside of direct patient care.
4. Recognize practical strategies for exploring and transitioning into nontraditional roles, including networking, skill development, and career positioning.

Genetic Counselor CEUs: 

The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, Emerging Career Paths for Genetic Counselors. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

Successful Completion: 

1. View recording
2. Pass quiz
3. Complete evaluation

Renal genetics is an emerging and rapidly evolving area of both genetics and nephrology practice, with relatively few specialists and growing demand for expertise. This webinar will provide a brief overview of nephrogenetics and highlight how genetic counselors are contributing to care delivery in this expanding specialty. Learners will hear perspectives from both a commercial laboratory genetic counselor and a clinical genetic counselor, with discussion of distinct service delivery models in nephrology genetics. Topics will include lab-led genetic information sessions, clinical practice models in renal genetics clinics, and examples of how different programs are addressing patient care, access, and workflow in this developing field.

Presented by:

NSGC Renal SIG
1. Mary-Beth Roberts, MS, CGC
2. Meg M. Hager, MS, MPH, CGC

Learning Objectives:

1. Summarize key concepts in nephrogenetics relevant to genetic counseling practice, including common indications for referral, major categories of renal genetic conditions, and the role of genetic testing in nephrology care.
2. Compare service delivery models in nephrology genetic counseling, including laboratory-based genetic information sessions and clinic-based renal genetics counseling models.
3. Describe the roles, responsibilities, and practice considerations of genetic counselors working in commercial laboratory and clinical nephrology settings.
4. Identify opportunities and challenges in implementing nephrology genetic counseling services by reviewing real-world examples from a lab-employed genetic counselor and clinical renal genetics programs.

Genetic Counselor CEUs 

The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, Service Delivery Models in Nephrology Genetic Counseling. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

Successful Completion: 

1. View recording
2. Pass quiz
3. Complete evaluation

In this interactive session, expert genetic counselors will walk through challenging cases that highlight evolving genetic knowledge, nuanced risk assessment, and the counseling strategies needed to support patients facing difficult decisions.

Presented by:

1. Leah Campbell, MS, CGC
2. Kaylee Dollerschell, MS, CGC
3. Meadow Heiman, MS, LCGC, CCRC

Learning Objectives:

1. Examine how targeted reflex RNA sequencing can provide functional splicing evidence to reclassify a variant of uncertain significance and inform clinical management and family risk assessment.
2. Evaluate a case with several clinical and psychosocial complexities while highlighting the importance of specimen type for germline testing.
3. Describe the clinical significance of deciphering HPFH from a sickle cell disease diagnosis.
4. Consider the unique genetic counseling issues in such cases.

Genetic Counselor CEUs: 

The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to 0.1 CEUs or 1 Category 1 contact hours for the activity, NSGC Case Based Webinar - Part II. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

Successful Completion: 

1. View recording
2. Pass quiz
3. Complete evaluation

This webinar will begin with background information on preimplantation genetic testing for aneuploidies (PGT-A) and mosaicism, including differences in lab reporting, historical viewpoints about mosaicism and transfer policies (and how that has evolved over time), and a quick summary of current literature on outcomes. The webinar will continue with how non-euploid embryo transfers are managed in a prenatal clinic, what testing (if any) patients are pursuing prenatally and/or postnatally, what the prenatal clinic is finding regarding outcomes and general trends, and cases examples.

Presented by:

NSGC Assisted Reproductive Technologies/Infertility SIG
Emma Moores, MGC, CGC
Jennifer Kussmann, MS, CGC

Learning Objectives:

1. Review the background on PGT-A testing with non-euploid results
2. Describe the historical viewpoints and current embryo transfer policies
3. Explain prenatal testing and screening options
4. Identify case examples to highlight the challenges in pregnancies with atypical embryos

Genetic Counselor CEUs: 

The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, The Mosaic Journey: From Transfer to Term. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

Successful Completion: 

1. View recording
2. Pass quiz
3. Complete evaluation